Boston Scientific makes a $850M acquisition, InBrain Neuroelectronics wins FDA breakthrough nod

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, September 20, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Virtual Incision this week added $30 million in funding for its miniaturized surgical robot. Fast Five hosts Sean Whooley and Danielle Kirsh explain the technology behind the robot and what the company plans to do with the proceeds from the funding round. Moon Surgical picked up CE mark approval this week for its updated Maestro surgical robot. Find out what the surgical robot does and how optimistic executives are about the future of the company. The FDA has granted investigational device exemption to Orchestra BioMed for its cardiac neuromod trial in pacemaker patients. Whooley explains what device is being studied and what the clinical trial will evaluate. InBrain Neuroelectronic won an FDA breakthrough nod for its intelligent network modulation system. Hear how the system works and what its designed for in today's episode. Boston Scientific is further entering the ablation market with its $850 million acquisition of Relievant Medsystems. The Fast Five hosts discuss what Relievant does and how the acquisition will support Boston Scientific's business.